5 Key Aspects to Examine When Selecting a Peptide Synthesis Service

The quality and reliability of your peptide synthesis service provider can directly impact development timelines, regulatory approvals, and ultimately, patient safety.

Peptides, often complex molecules that fall between small-molecule drugs and biologics, require specialized expertise to manufacture at high purity and yield.

Therefore, evaluating a peptide synthesis partner involves more than just basic cost and turnaround considerations. Below, we outline five key technical and strategic aspects to scrutinize to identify a truly reliable peptide manufacturing service.

1. GMP Compliance and Global Regulatory Track Record

First and foremost, it is essential to ensure the provider operates under Good Manufacturing Practice (GMP) standards and has a strong regulatory compliance history across major markets.

They must follow internationally harmonized guidelines such as ICH Q7 for active pharmaceutical ingredients (APIs) and maintain facilities that regulators routinely inspect.

A reliable peptide synthesis services partner should readily demonstrate compliance with US 21 CFR Parts 210/211, EU GMP guidelines (EudraLex Volume 4), Japanese MHLW requirements, and other global regulatory standards, providing you with confidence in their global regulatory standing.

Therefore, it is recommended to seek evidence of a solid track record, such as successful audits with no critical observations or warning letters. In summary, verify GMP certification and ask about the outcome of recent regulatory inspections in all relevant jurisdictions.

2. Analytical and Quality Control Capabilities

High-quality peptides require thorough characterization and impurity control; therefore, companies must assess the analytical techniques and quality control (QC) measures a peptide synthesis service provider has in place.

Use of orthogonal analytical methods

Regulatory agencies recommend an orthogonal approach, which involves the use of complementary analytical techniques to confirm the identity, purity, and potency of peptides. For example:

• High-performance liquid chromatography (HPLC) is commonly used to quantify purity
• High-resolution mass spectrometry (HRMS) can identify trace impurities

These combined techniques help detect impurities like truncated sequences, deletion variants, and oxidized forms that might otherwise go unnoticed

Comprehensive quality control toolkit

A truly reliable peptide synthesis service provider will possess a broad analytical toolkit that ensures the peptide meets all required specifications before batch release.

• Liquid chromatography-mass spectrometry (LC-MS) for molecular weight confirmation
• Amino acid analysis or peptide sequencing for identity verification
• Optical rotation or circular dichroism for chiral purity
• Karl Fischer titration for moisture content
• Endotoxin testing to determine if the peptide is intended for parenteral or in vivo use

Impurity identification and characterization

Beyond detecting impurities, top-tier peptide synthesis service providers actively characterize and understand byproducts.

This may involve additional methods such as ion-exchange chromatography (IEC) and size-exclusion chromatography (SEC). These techniques can reveal species that reverse-phase HPLC might miss, critical for ensuring consistent product quality and regulatory compliance.

3. Advanced Peptide Manufacturing Technologies

Two primary methods are commonly used: solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS), also known as solution-phase peptide synthesis.

• SPPS is highly efficient and automated for sequences typically up to around 30–50 amino acids in length​. 
• LPPS can be advantageous for very short peptides. It can yield high purity with simpler final purification, and it becomes more cost-effective as target quantities increase. 

A capable peptide synthesis services CDMO will have expertise in both SPPS and LPPS and will choose the optimal approach (or a combination) based on the peptide’s characteristics and the required scale​.

For more complex or long peptides, inquire whether the provider can implement hybrid synthesis strategies such as fragment condensation. This method is indispensable for very long peptides (50+ amino acids) or those prone to aggregation during chain assembly. 

Notably, some commercial peptides on the market (e.g., a 36-residue HIV fusion inhibitor) were produced by fragment coupling at multi-kilogram scale, demonstrating that hybrid techniques can achieve results that purely stepwise synthesis cannot​.

4. Proven Scale-Up Capabilities from R&D to Commercial Production

When evaluating a peptide synthesis service, consider their ability to take a project from early R&D quantities through clinical trial material and eventually to commercial-scale production. Look for:

• GMP suites and large-scale equipment: Large-volume peptide synthesizers, preparative HPLC systems, bulk lyophilizers, etc., are essential for the production of peptides at scale. It’s wise to ask for examples of peptides they have successfully scaled up.
• Chemical process optimization: Verify whether the provider has a team in place for tweaking coupling protocols, purification steps, and solvent schemes to maintain efficiency as batch size increases.
• Capacity for GMP production: If you anticipate needing multi-kilogram lots, ensure the CDMO has reactors and purification systems sized for that throughput, or at least a clear path to scale (some may start with smaller GMP batches and later transfer to a larger facility in their network).
• Scaling track record: For instance, some peptide synthesis service CDMOs, such as Neuland Labs, demonstrate a track record of manufacturing peptides on the order of tens of kilograms while meeting all regulatory requirements​. 

5. Expertise with Complex and Specialized Peptides

For a project involving complex peptides, such as long amino acid chains or cyclic structures, it is vital to vet the prospective service’s experience and capabilities in these areas.

Look for a track record of successfully producing long or “difficult sequence” peptides. For instance, Neuland Las has delivered 35 kg of a Decapeptide NCE (cGMP) produced by solution phase synthesis to a top US biotechnology company.

The service should demonstrate experience in cyclizing peptides, including the handling of cysteine oxidation for disulfide bond formation and the use of solution-phase cyclization for head-to-tail loops.

Many top peptide synthesis service providers will also offer a menu of peptide modifications and conjugations. This indicates a breadth of experience with chemically complex peptide conjugates (which is valuable if your project involves, say, antibody-drug conjugate payload peptides or peptide–oligonucleotide hybrids).

Partnering with Neuland Labs for Stellar Peptide Synthesis Services

Neuland Labs understands the critical demands of peptide synthesis services firsthand.

With over four decades of experience serving global pharmaceutical and biotechnology innovators, they bring a unique blend of scientific expertise, operational excellence, and regulatory integrity to every project.

Their peptide manufacturing capabilities are anchored in a state-of-the-art 9,800 sq. ft. dedicated peptide lab, equipped with seven additional hoods and staffed by a team of 25 skilled process chemists and 15 analytical scientists. 

In recognition of our sustainability and governance practices, Neuland Labs has also been honored as one of the Top 6 Indian companies in the Pharma/Biotech/Life Sciences services domain selected for the S&P Sustainability Yearbook 2024. 

When you choose Neuland Labs for your peptide synthesis services, you are partnering with a team that combines deep technical rigor with a future-forward vision.

Get in touch with Neuland Labs today to explore how our peptide synthesis services can support your next breakthrough.

---